Difference between revisions of "Wright MH, et al. Breast Cancer Res. (2008) cited as Ref 664 in DOI: 10.1038/s41392-020-0110-5 (Q9927)"
Jump to navigation
Jump to search
(Created claim: title (P93): Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): R10-, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | R10- | ||
| Property / Page(s): R10- / rank | |||
| + | Normal rank | ||
Latest revision as of 15:48, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wright MH, et al. Breast Cancer Res. (2008) cited as Ref 664 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wright MH
0 references
2008
0 references
Breast Cancer Res.
0 references
10
0 references
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics (English)
0 references
R10-
0 references
